Power Your Gene Therapy Pipeline With A Proven AAV CDMO Partner
With 30+ years of experience in viral vector development and manufacturing, we bring unmatched expertise as your trusted CDMO for AAV. From plasmids to fill/finish and advanced analytics, we provide true end-to-end support, accelerating your path to the clinic and beyond.
Empowering your AAV-based therapy from preclinical to commercial GMP manufacturing with speed and confidence:
- Our AAV Express Platform delivers scalable, reproducible, and high-performing solutions
- Our tailored tech transfer approach offers a comprehensive and flexible solution to de-risk and scale-up your program
Our Track Record
- 30+ Years of Development and Manufacturing Experience
- <12 Months to GMP Batch
- 50L to 2000L bClinical to Commercial Scalability
- 25+ In-house Analytical Assays
- >70 AAV Batches Produced
Confidence to Meet Every Milestone
Through a defined process designed by our technical experts you gain confidence in the clinical and commercial manufacturing of your AAV-based gene therapy.
Our AAV platform offers fully comprehensive support to reduce costs and meet your timelines:
- Packaging and transfer plasmids
- GMP-banked HEK293 cell line and media
- Extensive serotype experience
- Optimized GMP production
- On-site fill/ finish services
- Established and customized assays
- Regulatory support services
- Tech transfer capabilities
Discover Our AAV Express Platform
From plasmid design to fill/finish, our AAV Express platform delivers full-spectrum support to streamline production, cut costs, and accelerate your path to clinic and market in 12 months.
High Performance
- 8.5e11 vg/mL harvest titers
- 70-90% full capsids
- 30% recovery
Cost-savings
- Limited process optimization
- Standardized raw materials
- Templated production documents
Proven Scalable Production
- Development: 15mL to 200L
- GMP manufacturing: 50L to 2,000L
- Flexible operations
Technical Expertise
- AAV serotype experience (2, 5, 6, 8, 9, and more)
- 30+ Years of development and manufacturing experience
Comprehensive Analytics
- 25+ In-house panel of pre-qualified assays
- Customized characterization assays
- Onsite in-process and release testing
Regulatory Support
- IND/CTA initial authoring and review
- Submission amendment
- BLA/MAA finalization support
Accelerate Your AAV Therapy to Market with a CDMO You Can Trust
Partner with a team you can trust. Connect with us to discover how our AAV Express platform delivers a cost-effective, de-risked, and streamlined path to GMP production.